vs

Side-by-side financial comparison of MEDIFAST INC (MED) and IMPINJ INC (PI). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $74.3M, roughly 1.0× IMPINJ INC). On growth, IMPINJ INC posted the faster year-over-year revenue change (-0.0% vs -36.9%). IMPINJ INC produced more free cash flow last quarter ($2.2M vs $-6.6M). Over the past eight quarters, IMPINJ INC's revenue compounded faster (-14.9% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Impinj, Inc. is an American manufacturer of radio-frequency identification (RFID) devices and software. The company was founded in 2000 and is headquartered in Seattle, Washington. The company was started based on the research done at the California Institute of Technology by Carver Mead and Chris Diorio. Impinj currently produces EPC Class 1, Gen 2 passive UHF RFID chips, RFID readers, RFID reader chips, and RFID antennas, and software applications for encoding chips, and gathering business ...

MED vs PI — Head-to-Head

Bigger by revenue
MED
MED
1.0× larger
MED
$75.1M
$74.3M
PI
Growing faster (revenue YoY)
PI
PI
+36.9% gap
PI
-0.0%
-36.9%
MED
More free cash flow
PI
PI
$8.9M more FCF
PI
$2.2M
$-6.6M
MED
Faster 2-yr revenue CAGR
PI
PI
Annualised
PI
-14.9%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
PI
PI
Revenue
$75.1M
$74.3M
Net Profit
$8.3M
Gross Margin
69.4%
49.1%
Operating Margin
-10.4%
30.5%
Net Margin
11.2%
Revenue YoY
-36.9%
-0.0%
Net Profit YoY
EPS (diluted)
$-1.64
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
PI
PI
Q1 26
$74.3M
Q4 25
$75.1M
$92.8M
Q3 25
$89.4M
$96.1M
Q2 25
$105.6M
$97.9M
Q1 25
$115.7M
$74.3M
Q4 24
$119.0M
$91.6M
Q3 24
$140.2M
$95.2M
Q2 24
$168.6M
$102.5M
Net Profit
MED
MED
PI
PI
Q1 26
$8.3M
Q4 25
$-1.1M
Q3 25
$-2.3M
$-12.8M
Q2 25
$2.5M
$11.6M
Q1 25
$-772.0K
$-8.5M
Q4 24
$-2.7M
Q3 24
$1.1M
$221.0K
Q2 24
$-8.2M
$10.0M
Gross Margin
MED
MED
PI
PI
Q1 26
49.1%
Q4 25
69.4%
51.8%
Q3 25
69.5%
50.3%
Q2 25
72.6%
57.8%
Q1 25
72.8%
49.4%
Q4 24
74.1%
50.5%
Q3 24
75.4%
50.0%
Q2 24
73.2%
56.1%
Operating Margin
MED
MED
PI
PI
Q1 26
30.5%
Q4 25
-10.4%
-2.9%
Q3 25
-4.6%
0.7%
Q2 25
-1.0%
11.1%
Q1 25
-1.1%
-12.9%
Q4 24
0.6%
-3.9%
Q3 24
1.5%
-0.8%
Q2 24
-4.7%
8.8%
Net Margin
MED
MED
PI
PI
Q1 26
11.2%
Q4 25
-1.2%
Q3 25
-2.5%
-13.3%
Q2 25
2.3%
11.8%
Q1 25
-0.7%
-11.4%
Q4 24
-2.9%
Q3 24
0.8%
0.2%
Q2 24
-4.8%
9.7%
EPS (diluted)
MED
MED
PI
PI
Q1 26
$0.14
Q4 25
$-1.64
$-0.02
Q3 25
$-0.21
$-0.44
Q2 25
$0.22
$0.39
Q1 25
$-0.07
$-0.30
Q4 24
$0.08
$-0.06
Q3 24
$0.10
$0.01
Q2 24
$-0.75
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
PI
PI
Cash + ST InvestmentsLiquidity on hand
$167.3M
$131.8M
Total DebtLower is stronger
$241.5M
Stockholders' EquityBook value
$198.9M
Total Assets
$248.0M
$502.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
PI
PI
Q1 26
$131.8M
Q4 25
$167.3M
$175.3M
Q3 25
$173.5M
$190.1M
Q2 25
$162.7M
$193.2M
Q1 25
$164.6M
$147.9M
Q4 24
$162.3M
$164.7M
Q3 24
$170.0M
$170.3M
Q2 24
$163.5M
$220.2M
Total Debt
MED
MED
PI
PI
Q1 26
$241.5M
Q4 25
$280.9M
Q3 25
$280.4M
Q2 25
Q1 25
Q4 24
$283.5M
Q3 24
Q2 24
Stockholders' Equity
MED
MED
PI
PI
Q1 26
Q4 25
$198.9M
$209.2M
Q3 25
$214.7M
$195.0M
Q2 25
$216.0M
$187.7M
Q1 25
$211.0M
$160.6M
Q4 24
$210.1M
$149.9M
Q3 24
$207.3M
$136.1M
Q2 24
$205.3M
$117.0M
Total Assets
MED
MED
PI
PI
Q1 26
$502.5M
Q4 25
$248.0M
$545.2M
Q3 25
$268.2M
$516.5M
Q2 25
$269.3M
$508.8M
Q1 25
$280.0M
$479.8M
Q4 24
$284.2M
$489.1M
Q3 24
$291.2M
$476.4M
Q2 24
$293.5M
$446.1M
Debt / Equity
MED
MED
PI
PI
Q1 26
Q4 25
1.34×
Q3 25
1.44×
Q2 25
Q1 25
Q4 24
1.89×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
PI
PI
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
$2.2M
FCF MarginFCF / Revenue
-8.8%
3.0%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$61.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
PI
PI
Q1 26
Q4 25
$-5.3M
$15.1M
Q3 25
$12.1M
$20.9M
Q2 25
$-3.4M
$33.9M
Q1 25
$3.4M
$-11.1M
Q4 24
$-4.9M
$12.6M
Q3 24
$9.1M
$10.1M
Q2 24
$13.1M
$45.5M
Free Cash Flow
MED
MED
PI
PI
Q1 26
$2.2M
Q4 25
$-6.6M
$13.6M
Q3 25
$10.8M
$18.0M
Q2 25
$-4.8M
$27.3M
Q1 25
$1.9M
$-13.0M
Q4 24
$-7.2M
$8.5M
Q3 24
$7.7M
$4.7M
Q2 24
$11.1M
$44.1M
FCF Margin
MED
MED
PI
PI
Q1 26
3.0%
Q4 25
-8.8%
14.7%
Q3 25
12.0%
18.7%
Q2 25
-4.5%
27.9%
Q1 25
1.6%
-17.5%
Q4 24
-6.1%
9.3%
Q3 24
5.5%
4.9%
Q2 24
6.6%
43.0%
Capex Intensity
MED
MED
PI
PI
Q1 26
Q4 25
1.8%
1.6%
Q3 25
1.5%
3.1%
Q2 25
1.3%
6.7%
Q1 25
1.3%
2.5%
Q4 24
1.9%
4.5%
Q3 24
1.0%
5.7%
Q2 24
1.1%
1.3%
Cash Conversion
MED
MED
PI
PI
Q1 26
Q4 25
Q3 25
Q2 25
-1.36×
2.93×
Q1 25
Q4 24
Q3 24
8.04×
45.56×
Q2 24
4.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons